{
  "url": "https://struct.news/briefs/amneals-profit-surged-its-inventory-and-cash-conversion-did-not-keep-pace",
  "title": "Amneal’s profit surged. Its inventory and cash conversion did not keep pace",
  "summary": "Net income jumped 157% to $57.7 million, while free-cash-flow margin fell 9.6 percentage points.",
  "published_at": "2026-08-06T21:26:32.449662+00:00",
  "publisher": "Struct",
  "usage": "Figures are as reported by the company. Quote with attribution to the source filing.",
  "company": {
    "name": "Amneal Pharmaceuticals, Inc.",
    "ticker": "AMRX",
    "cik": "1723128",
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Specialty & Generic"
  },
  "source_filing": {
    "form": "10-Q",
    "filed": "2026-08-06",
    "accession": "0001723128-26-000031",
    "url": "https://www.sec.gov/Archives/edgar/data/1723128/000172312826000031/amrx-20260630.htm"
  },
  "comparison_filing": {
    "form": "10-Q",
    "filed": "2025-08-07",
    "url": "https://www.sec.gov/Archives/edgar/data/1723128/000172312825000047/amrx-20250630.htm"
  },
  "reported_figures": [
    {
      "group": "The filing in three numbers",
      "label": "Revenue",
      "value": 3018760000,
      "display": "$3.0B",
      "unit": "usd",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "sec_filing",
        "label": "Filed company results",
        "form": "10-Q",
        "accession": "0001723128-26-000031",
        "filing_date": "2026-08-06"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Revenue YoY",
      "value": 8.04604365779431,
      "display": "+8.0%",
      "unit": "percent",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001723128-26-000031",
        "filing_date": "2026-08-06"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Operating margin",
      "value": 13.054896712557474,
      "display": "+13.1%",
      "unit": "percent",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001723128-26-000031",
        "filing_date": "2026-08-06"
      }
    }
  ],
  "watch_next": [
    {
      "type": "demand",
      "statement": "Affordable Medicines margin rose as recently launched products and higher sales volumes improved mix, partly offset by plant, freight, and inventory-obsolescence costs.",
      "importance": "medium",
      "evidence": "Affordable Medicines gross profit as a percentage of net revenue increased to 42.3% for the three months ended June 30, 2026 from 41.7% in the prior year period, primarily due to favorable product mix from recently launched products and higher sales volumes",
      "source_date": "2026-08-06"
    }
  ],
  "related_tickers": [
    "AMRX"
  ],
  "disclaimer": "Descriptive reporting of filed results. Not investment advice, and contains no forecast or recommendation."
}